Monitor for subsequent prospectus supplements or 424B filings indicating the company's intent to draw on the shelf. For a clinical-stage biotech with no approved products, shelf effectiveness typically signals near-term capital raising.
Price Chart
Executive Summary
Can-Fite BioPharma's F-3 shelf registration (File No. 333-298625) became effective on October 9, 2026. This allows the company to offer and sell securities from time to time, creating potential dilution overhang for existing common shareholders.
Key Facts
- F-3 shelf registration declared effective on 2026-10-09
- File No. 333-298625 under the 1933 Act
- Can-Fite BioPharma is a clinical-stage biopharmaceutical company
Financial Impact
Potential future dilution from at-the-market or follow-on offerings; no specific dollar amount disclosed in the EFFECT notice
Risk Factors
- Potential equity dilution if the company conducts an offering under the shelf
- No disclosure of specific use of proceeds or offering size in this filing
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-003201 |
| Document: 9999999995-26-003201-index.html | 9999999995-26-003201 |
| Document: 9999999995-26-003201.txt | 9999999995-26-003201 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | $1.95 | awaiting T+5 | — | $1.72 (−11.79%) |
Oct 13, 2026 13d ago | EFFECT | $1.95 $1.89 | ▲ +3.08% | ▲ +1.93% | $1.72 (+11.79%) |
Oct 13, 2026 13d ago | EFFECT | $1.95 $1.89 | ▲ +3.08% | ▲ +1.93% | $1.72 (+11.79%) |
Sep 14, 2026 6w ago | EFFECT | $2.30 $2.22 | ▲ +3.48% | ▲ +3.58% | $1.72 (+25.22%) |
Sep 9, 2026 6w ago | 6-K | $2.19 $2.24 | ▲ +2.28% | ▲ +3.38% | $1.72 (−21.46%) |
Sep 3, 2026 7w ago | 6-K | $2.35 $2.33 | ▼ −0.85% | ▲ +0.30% | $1.72 (−26.81%) |
Sep 2, 2026 7w ago | 6-K | $2.36 $2.16 | ▼ −8.47% | ▼ −7.52% | $1.72 (−27.12%) |
Sep 2, 2026 7w ago | Press Release | $2.36 $2.16 | ▲ +8.47% | ▲ +7.52% | $1.72 (+27.12%) |
Sep 2, 2026 7w ago | 6-K | $2.36 $2.16 | ▼ −8.47% | ▼ −7.52% | $1.72 (−27.12%) |
Aug 17, 2026 10w ago | 6-K | $3.58 $3.35 | ▼ −6.42% | ▼ −5.23% | $1.72 (−51.96%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers